Top Upgrades
- Argus upgraded Lululemon Athletica inc. LULU from Hold to Buy. Lululemon shares rose 1.02 percent to $127.74 in pre-market trading.
- Morgan Stanley upgraded Embraer SA (ADR) ERJ from Equal-Weight to Overweight. Embraer shares fell 2.51 percent to close at $18.65 on Wednesday.
- Analysts at Compass Point upgraded GreenSky Inc GSKY from Neutral to Buy. GreenSky shares fell 1.83 percent to $15.62 in pre-market trading.
- Canaccord Genuity upgraded Canopy Growth Corp CGC from Hold to Speculative Buy. Canopy Growth shares rose 2.93 percent to $33.05 in pre-market trading.
- Jefferies upgraded TechnipFMC PLC FTI from Hold to Buy. TechnipFMC shares rose 1.27 percent to $27.95 in pre-market trading.
- Goldman Sachs upgraded Avalara Inc AVLR from Neutral to Buy. Avalara shares rose 6 percent to $36.75 in pre-market trading.
- JP Morgan upgraded Kimberly Clark Corp KMB from Underweight to Neutral. Kimberly-Clark shares rose 0.46 percent to $116.99 in pre-market trading.
Top Downgrades
- Macquarie downgraded Himax Technologies, Inc. (ADR) HIMX from Outperform to Neutral. Himax shares fell 8 percent to close at $5.98 on Wednesday.
- Morgan Stanley downgraded Healthcare Trust Of America Inc HTA from Overweight to Equal-Weight. Healthcare Trust shares fell 0.48 percent to $28.82 in pre-market trading.
- DA Davidson downgraded Nanometrics Incorporated NANO from Buy to Neutral. Nanometrics shares fell 2.39 percent to $44.14 in pre-market trading.
- HSBC downgraded Cemex SAB de CV (ADR) ADR CX from Buy to Hold. Cemex shares fell 3.82 percent to close at $6.79 on Wednesday.
- Canaccord Genuity downgraded Cenovus Energy Inc CVE from Buy to Hold. Cenovus Energy shares rose 1.67 percent to $9.10 in pre-market trading.
- Jefferies downgraded AstraZeneca plc (ADR) AZN from Buy to Hold. AstraZeneca shares fell 0.34 percent to $38.32 in pre-market trading.
- Barclays downgraded Grupo Aeroportuario del Centro Nort(ADR) OMAB from Overweight to Equal-Weight. Grupo Aeroportuario del Centro Nort(ADR) shares fell 3.04 percent to close at $49.40 on Wednesday.
- KeyBanc downgraded Multi-Color Corporation LABL from Sector Weight to Underweight. Multi-Color shares fell 0.01 percent to $63.84 in pre-market trading.
- Bank of America downgraded Coty Inc COTY from Buy to Underperform. Coty shares fell 2.19 percent to $11.18 in pre-market trading.
Top Initiations
- UBS initiated Lockheed Martin Corporation LMT with a Buy rating. The price target for Lockheed Martin is set to $400. Lockheed Martin shares closed at $317.70 on Wednesday.
- Leerink Swann initiated coverage on Teladoc Health Inc TDOC with an Outperform rating. The price target for Teladoc Health is set to $90. Teladoc Health shares closed at $70.75 on Wednesday.
- Analysts at H.C. Wainwright initiated coverage on AVEO Pharmaceuticals, Inc. AVEO with a Buy rating. The price target for AVEO Pharmaceuticals is set to $6.50. AVEO Pharmaceuticals shares closed at $2.18 on Wednesday.
- Analysts at UBS initiated coverage on Northrop Grumman Corporation NOC with a Neutral rating. The price target for Northrop Grumman is set to $315. Northrop Grumman shares closed at $291.51 on Wednesday.
- Piper Jaffray initiated coverage on Post Holdings Inc POST with an Overweight rating. The price target for Post Holdings is set to $115. Post Holdings closed at $94.78 on Wednesday.
- BTIG Research initiated coverage on Stryker Corporation SYK with a Buy rating. The price target for Stryker is set to $187. Stryker shares closed at $166.78 on Wednesday.
- Jefferies initiated coverage on Conn's Inc CONN with a Buy rating. The price target for Conn's is set to $44. Conn's shares closed at $33.85 on Wednesday.
- Analysts at Chardan Capital initiated coverage on eHealth, Inc. EHTH with a Buy rating. The price target for eHealth is set to $40. eHealth closed at $29.04 on Wednesday.
- Ladenburg Thalmann initiated coverage on AcelRx Pharmaceuticals Inc ACRX with a Buy rating. The price target for AcelRx Pharmaceuticals is set to $7. AcelRx Pharmaceuticals shares closed at $2.95 on Wednesday.
- Analysts at UBS initiated coverage on Hexcel Corporation HXL with a Sell rating. The price target for Hexcel is set to $65. Hexcel closed at $68.42 on Wednesday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In: UpgradesDowngradesInitiationPre-Market OutlookAnalyst RatingsAerospace & DefenseApparel, Accessories & Luxury GoodsConsumer DiscretionaryIndustrialsInformation TechnologyInitiationsSemiconductor Equipmenttop upgrades
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in